He also serves on the board of Kimberly-Clark Corporation. News Release -- February 06, 2020 TYSONS, Va., Feb. 6, 2020 – DXC Technology (NYSE: DXC) today announced that the board of directors has elected Ian Read, former chairman and chief executive officer of Pfizer, as its new chairman. Tweet this. ... DXC Technology Names Ian Read, Former Chairman and CEO of Pfizer, as Board Chairman. DXC Technology Names Ian Read, Former Chairman and CEO of Pfizer, as Board Chairman Business Wire TYSONS, Va. -- February 6, 2020 DXC Technology (NYSE: DXC… The largest trade he's ever made was exercising 1,100,201 units of Kimberly-Clark stock on 2 November 2018 worth over $29,309,355. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. DXC Technology Names Ian Read, Former Chairman and CEO of Pfizer, as Board Chairman Published: Feb 06, 2020 TYSONS, Va.--( BUSINESS WIRE )-- DXC Technology (NYSE: DXC) today announced that the board of directors has elected Ian Read, former chairman and … DXC Technology announced that the board of directors has elected Ian Read, former chairman and chief executive officer of Pfizer, as its new chairman. Most recently he sold 530,078 units of KMB stock worth $22,883,467 on 4 March 2019.. He is also Member of President's Export Council and on the board of 11 other companies. DXC Technology, an end-to-end information technology services company, issued the following news release: DXC Technology (NYSE: DXC) announced that the board of directors has elected Ian Read, former chairman and chief executive officer of Pfizer, as its new chairman.

Feb 6, 2020 DXC Technology Names Ian Read as Chairman Dow Jones Newswires Jan 25, 2020 This basket of dividend growth stocks can help your portfolio stand out in 2020 MarketWatch.com He spent 41 years with the pharmaceutical giant. According to Manoj Singh, head of the board’s nominating/corporate governance committee, Read’s appointment will become effective on March 16.

According to Manoj Singh, head of the board’s nominating/corporate governance committee, Read’s appointment will become effective on March 16.

At the time of its creation, DXC Technology had revenues of $25 billion, employed 170,000 people … Insiders are officers, directors, or significant investors in a company. Ian has 10 jobs listed on their profile. According to Manoj Singh, head of the board’s nominating/corporate governance committee, Read’s appointment will become effective on March 16. “In DXC, I see the makings of a true global leader in IT services,” Read said in a statement. The oldest executive at DXC Technology Co. is Ian Read, 66, who is the Chairman of the Board. Insiders trading at DXC Technology Co Over the last 3 years, insiders at DXC Technology Co have traded over $49,552,989 worth of DXC Technology Co stock and bought 18,666 units worth $971,719 . Currently, Ian C. Read is Chairman at DXC Technology Co. Read will replace David Herzog in March having retired as Pfizer's executive chairman at the end of last year. NATALIE YEADON; Newsletters; Webinars; Feed; Groups. DXC Technology Company provides information technology services. Former Pfizer CEO Ian Read has been named as DXC Technology's new chairman. Many … READ IAN C insider trades in DXC Technology Company are found here. I am thrilled that Ian Read, the retired Chairman and CEO of Pfizer, will be joining us as our new Chairman. Former Pfizer CEO Ian Read has been named as DXC Technology's new chairman. Ian has made over 21 trades of the Kimberly-Clark stock since 2007, according to the Form 4 filled with the SEC. DXC Technology Company -- Moody's says DXC's senior unsecured notes issuance does not affect the Baa2 senior unsecured rating or negative outlook. Unfortunately, you don't own enough credit to see this new org chart.

Salvino said he is thrilled that Read is joining DXC as chairman of the board. To continue, you can add a name in one of the org charts you recently viewed or test our Premium membership. DXC Technology (NYSE: DXC) today announced that the board of directors has elected Ian Read, former chairman and chief executive officer of Pfizer, as its new chairman.. DXC Technology was founded in 2017 as the result of the spin-off of Hewlett Packard Enterprise's Enterprise Service segment and its merger with Computer Sciences Corporation (CSC). Ian C. Read, 65 Chairman, DXC Technology Co. Ian C. Read occupies the position of Chairman for DXC Technology Co. FEATURED WRITERS. Ian Read Biography. Ian Read served as Pfizer Inc.’s executive chairman until his retirement on December 31, 2019, completing a 41-year career with the global pharmaceutical company.

TYSONS, Va.--(BUSINESS WIRE)--DXC Technology (NYSE: DXC) today announced that the board of directors has elected Ian Read, former chairman and chief executive officer of Pfizer, as its new chairman.According to Manoj Singh, head of the board’s nominating/corporate governance committee, Read’s appointment will become effective on March 16. He spent 41 years with the pharmaceutical giant. TYSONS, Va., Feb. 6, 2020 – DXC Technology (NYSE: DXC) today announced that the board of directors has elected Ian Read, former chairman and chief executive officer of Pfizer, as its new chairman. In general, it is generally illegal for insiders to make trades in their companies based on specific, non-public information. “In DXC, I see the makings of a true global leader in IT services,” Read said in a statement.